课题基金 / 基金详情

项目摘要

项目成果

VISHWA DEEP DIXIT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project summary The resident gut microbiota and the host immune system have co-evolved for millennia. However, modern societal conditions have disturbed this co-evolution, coinciding with a steep rise in immune-mediated diseases. Bacterial translocation across the intestinal barrier and into extraintestinal organs such as the visceral adipose tissues can have major pathological consequences. We recently discovered that aging is associated with formation of tertiary lymphoid structures, known as Fat-associated lymphoid clusters (FALCs), in the visceral adipose tissue. As an individual ages, the abundance of anti-inflammatory gut bacteria decreases with a parallel increase in opportunistic pathogens, ultimately leading to disruption of intestinal immunity and barrier function. In two recent studies, the gut commensal species Enterococcus gallinarum was found to have high translocation efficacy, with the ability to translocate to the liver and induce autoimmunity in genetically predisposed mice. In our preliminary experiments, we found that two different strains of E. gallinarum exhibit distinct capacities for translocation, and that rates of translocation for a single E. gallinarum strain vary dramatically between mice mono-colonized with E. gallinarum versus mice colonized with E. gallinarum in the presence of a complex gut microbial community. We hypothesize that translocation of gut microbes to visceral adipose tissue results in FALC formation and age-related inflammation leading to metabolic dysfunction. In this application, we propose to: 1) determine the effect of E. gallinarum translocation and persistence on aging-associated FALC formation and inflammation, and 2) elucidate the mechanism(s) that enable E. gallinarum to translocate and induce aging- associated FALC formation and inflammation. These studies will provide insight into the fundamental mechanisms by which commensal bacteria translocate across the intestinal barrier and induce age-related inflammation. Thus, they may illuminate potential targets for novel therapeutic strategies delay chronic aging with age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Caloric restriction-driven immunometabolic checkpoints of inflammation
  • 批准号:
    10457565
  • 项目类别:
  • 资助金额:
    $58.39万
  • 财政年份:
    2022
  • 负责人:
    VISHWA DEEP DIXIT
  • 依托单位:
Yale Murine-TMC on Immune Cell Senescence Derived Inflammation
  • 批准号:
    10675111
  • 项目类别:
  • 资助金额:
    $165.13万
  • 财政年份:
    2022
  • 负责人:
    VISHWA DEEP DIXIT
  • 依托单位:
Caloric restriction-driven immunometabolic checkpoints of inflammation
  • 批准号:
    10656332
  • 项目类别:
  • 资助金额:
    $55.01万
  • 财政年份:
    2022
  • 负责人:
    VISHWA DEEP DIXIT
  • 依托单位:
Immunometabolic regulation of bone inflammaging
  • 批准号:
    10430514
  • 项目类别:
  • 资助金额:
    $50.25万
  • 财政年份:
    2022
  • 负责人:
    VISHWA DEEP DIXIT
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: